Globus Medical Reports Second Quarter 2016 Results

Go back to Globus Medical Reports Second Quarter 2016 Results

UPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to Hold

July 27, 2016 7:17 AM EDT

(Updated - July 27, 2016 10:39 AM EDT)

Canaccord Genuity downgraded Globus Medical (NYSE: GMED) from Buy to Hold with a price target of $28.00 (from $30.00). Analyst Kyle Rose expressed concerns that its US business slow to regain momentum.

Rose explained, "We... More

Wells Fargo Upgrades Globus Medical (GMED) to Market Perform

July 27, 2016 7:16 AM EDT

Wells Fargo upgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.

Shares of Globus Medical closed at $26.43 yesterday.

... More

Globus Medical (GMED) to Acquire Alphatec International Business in $80M Deal

July 26, 2016 4:39 PM EDT

Globus Medical, Inc. (NYSE: GMED) announced that it has entered into an agreement to acquire the international operations and distribution channels of Alphatec Holdings, Inc., a publicly traded medical devices company (Nasdaq: ATEC) for $80.0 million in cash, subject to certain closing adjustments. Globus Medical also agreed to extend a 5-year senior secured credit facility of up to $30.0 million to Alphatec to support their working capital needs. The parties expect the closing of the acquisition to occur by October 2016 following... More